Enhanced Recovery After Surgery Protocol Compared to Conventional Care in Gynecological Cancer Surgery at a Tertiary Hospital

What this Trial Is About

Researchers are studying the use of Enhanced Recovery After Surgery ERAS protocols in the management of gynecological oncology surgeries. ERAS is a multimodal care approach designed to speed up recovery after surgery by maintaining organ function and reducing surgical stress. This study compares ERAS to conventional surgical care to evaluate outcomes like hospital stay, pain, complications, and costs in patients with cervical, uterine, or ovarian cancer. Participants will be randomly assigned to one of two groups. The ERAS group will follow a protocol including patient education, no bowel preparation, controlled fasting, limited fluid use, opioid-sparing pain management, early catheter and drain removal, and encouragement of early movement and diet resumption. The conventional group will receive standard care with bowel preparation, longer fasting, more fluid use, narcotic analgesia, prolonged immobilization, and delayed diet and catheter removal. The study will run from April 2024 to March 2026, with 160 patients enrolled. During the study, researchers will assess factors such as hospital stay length 3 to 4 days, time to first bowel movement, pain levels, nausea, complications, readmission rates, mortality, and total hospital costs. Patients will be closely monitored through the preoperative, intraoperative, and postoperative phases. Data will be analyzed to determine the impact of ERAS on recovery and healthcare resource use compared to conventional methods.

Enhanced Recovery After Surgery(ERAS) Following Gynaecological Oncology Surgery in a Tertiary Level Hospital